T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WR
1576
DELISTED
Westar Energy Inc
WR
| $2.09M | ﹤0.01% |
53,850
+8,900
| +20% | +$358K |
|
1577
Avnet
AVT
$7.87B
| $2.08M | ﹤0.01% |
46,798
| – | – |
|
1578
Alliant Energy
LNT
$18.2B
| $2.08M | ﹤0.01% |
66,096
+1,000
| +2% | +$32.6K |
|
1579
Reinsurance Group of America
RGA
$16.4B
| $2.05M | ﹤0.01% |
22,020
+1,000
| +5% | +$88.3K |
|
1580
Voya Financial
VOYA
$9.16B
| $2.02M | ﹤0.01% |
46,800
+14,000
| +43% | +$590K |
|
|
BRCD
1581
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $1.98M | ﹤0.01% |
166,606
+1,681
| +1% | +$20.1K |
|
1582
Galicia Financial Group
GGAL
$7.23B
| $1.96M | ﹤0.01% |
84,550
+37,340
| +79% | +$737K |
|
1583
NVR
NVR
$17B
| $1.96M | ﹤0.01% |
1,473
-90
| -6% | -$118K |
|
1584
iShares MSCI Japan ETF
EWJ
$23.2B
| $1.93M | ﹤0.01% |
38,500
+10,475
| +37% | +$501K |
|
|
PRE
1585
DELISTED
PARTNERRE LTD
PRE
| $1.92M | ﹤0.01% |
16,800
+200
| +1% | +$23K |
|
1586
AXIS Capital
AXS
$7.3B
| $1.92M | ﹤0.01% |
37,200
-3,374
| -8% | -$172K |
|
1587
Bio-Techne
TECH
$11.2B
| $1.92M | ﹤0.01% |
76,492
+4,040
| +6% | +$96K |
|
1588
Commercial Metals
CMC
$7.98B
| $1.9M | ﹤0.01% |
117,200
-474,480
| -80% | -$6.93M |
|
|
XLS
1589
DELISTED
EXELIS INC COM STK
XLS
| $1.89M | ﹤0.01% |
77,555
+10,355
| +15% | +$221K |
|
1590
Broadridge
BR
$19.6B
| $1.88M | ﹤0.01% |
34,225
-4,800
| -12% | -$244K |
|
|
STRI
1591
DELISTED
STR HLDGS INC COM STK NEW (DE)
STRI
| $1.88M | ﹤0.01% |
1,311,757
+1,298
| +0.1% | +$2.1K |
|
1592
CoreCivic
CXW
$3.13B
| $1.87M | ﹤0.01% |
46,404
| – | – |
|
1593
National Fuel Gas
NFG
$7.75B
| $1.84M | ﹤0.01% |
30,454
+4,024
| +15% | +$259K |
|
1594
Arch Capital
ACGL
$33.5B
| $1.83M | ﹤0.01% |
89,349
-34,155
| -28% | -$684K |
|
1595
VEON
VEON
$3.93B
| $1.83M | ﹤0.01% |
+14,004
| New | +$1.65M |
|
|
FLG
1596
Flagstar Bank National Association
FLG
$5.92B
| $1.83M | ﹤0.01% |
36,465
+1,823
| +5% | +$88.7K |
|
1597
Sonoco
SON
$5.77B
| $1.82M | ﹤0.01% |
39,937
+4,250
| +12% | +$192K |
|
|
UNT
1598
DELISTED
UNIT Corporation
UNT
| $1.79M | ﹤0.01% |
64,000
-11,800
| -16% | -$351K |
|
1599
Carlisle Companies
CSL
$14.9B
| $1.75M | ﹤0.01% |
18,844
-2,100
| -10% | -$193K |
|
1600
Cabot Corp
CBT
$4.45B
| $1.72M | ﹤0.01% |
38,250
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.